Saltar al contenido
República del Perú · Observatorio de la producción científica universitaria
OApol.org Observatorio de Inteligencia Científica Universitaria del Perú
OApol.org
Inicio Universidades Publicaciones Investigadores
Repositorios
Tesis y trabajos académicosRevistas
Indicadores
Ranking trimestralRanking por carreraObjetivos de Desarrollo SostenibleReporte OCDERed neuronal 3D
Acerca
MetodologíaPrivacidad

Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients

Reichmuth M.L.; Hömke R.; Zürcher K.; Sander P.; Avihingsanon A.; Collantes J.; Loiseau C.; Borrell S.; Reinhard M.; Wilkinson R.J.; Yotebieng M.; Fenner L.; Böttger E.C.; Gagneux S.; Egger M.; Keller P.M. · Antimicrobial Agents and Chemotherapy (2020) · DOI: 10.1128/aac.00513-20

Resumen

Mutations in the genes of the F420 signaling pathway of Mycobacterium tuberculosis complex, including dnn, fgd1, fbiA, fbiB, fbiC, and fbiD, can lead to delamanid resistance. We searched for such mutations among 129 M. tuberculosis strains from Asia, South America, and Africa using whole-genome sequencing; 70 (54%) strains had at least one mutation in one of the genes. For 10 strains with mutations, we determined the MIC of delamanid. We found one strain from a delamanid-naive patient carrying the natural polymorphism Tyr29del (ddn) that was associated with a critical delamanid MIC. Copyright

Instituciones: Universidad Peruana Cayetano Heredia